Central administration of ghrelin alters emotional responses in rats: Behavioural, electrophysiological and molecular evidence

Neuroscience

Volumn 180, Issue , 2011, Pages 201-211

  Hansson, C ^a   Haage, D ^a,b   Taube, M ^a   Egecioglu, E ^a   Salome N ^a   Dickson, S L ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Anxiety; Depression; Emotional reactivity; GHS R1A; Memory; Serotonin

Indexed keywords

GHRELIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; DEPRESSION; DORSAL RAPHE NUCLEUS; EMOTION; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; ELECTROPHYSIOLOGY; EMOTIONS; GENE EXPRESSION; GHRELIN; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79953196100     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.02.002     Document Type: Article

References (72)

1. Abercrombie H.C., Schaefer S.M., Larson C.L., Oakes T.R., Lindgren K.A., Holden J.E., Perlman S.B., Turski P.A., Krahn D.D., Benca R.M., Davidson R.J. Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuroreport 1998, 9:3301-3307.
2. Abildgaard A, Solskov L, Volke V, Harvey BH, Lund S, Wegener G (in press) A high-fat diet exacerbates depressive-like behavior in the Flinders Sensitive Line (FSL) rat, a genetic model of depression. Psychoneuroendocrinology, in press.
3. Abizaid A., Liu Z.W., Andrews Z.B., Shanabrough M., Borok E., Elsworth J.D., Roth R.H., Sleeman M.W., Picciotto M.R., Tschop M.H., Gao X.B., Horvath T.L. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest 2006, 116:3229-3239.
4. Aroniadou-Anderjaska V., Qashu F., Braga M.F.M. Mechanisms regulating GABAergic inhibitory transmission in the basolateral amygdala: implications for epilepsy and anxiety disorders. Amino Acids 2007, 32:305-315.
5. Asakawa A., Inui A., Kaga T., Yuzuriha H., Nagata T., Fujimiya M., Katsuura G., Makino S., Fujino M.A., Kasuga M. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 2001, 74:143-147.
6. Ashton J.C., Darlington C.L., Smith P.F. Co-distribution of the cannabinoid CB1 receptor and the 5-HT transporter in the rat amygdale. Eur J Pharmacol 2006, 537:70-71.
7. Bajic D., Hoang Q.V., Nakajima S., Nakajima Y. Dissociated histaminergic neuron cultures from the tuberomammillary nucleus of rats: culture methods and ghrelin effects. J Neurosci Methods 2004, 132:177-184.
8. Braga M.F.M., Aroniadou-Anderjaska V., Xie J.W., Li H. Bidirectional modulation of GABA release by presynaptic glutamate receptor 5 kainate receptors in the basolateral amygdala. J Neurosci 2003, 23:442-452.
9. Carlini V.P., Martini A.C., Schioth H.B., Ruiz R.D., Fiol de Cuneo M., de Barioglio S.R. Decreased memory for novel object recognition in chronically food-restricted mice is reversed by acute ghrelin administration. Neuroscience 2008, 153:929-934.
10. Carlini V.P., Monzon M.E., Varas M.M., Cragnolini A.B., Schioth H.B., Scimonelli T.N., de Barioglio S.R. Ghrelin increases anxiety-like behavior and memory retention in rats. Biochem Biophys Res Commun 2002, 299:739-743.
11. Carlini V.P., Varas M.M., Cragnolini A.B., Schioth H.B., Scimonelli T.N., de Barioglio S.R. Differential role of the hippocampus, amygdala, and dorsal raphe nucleus in regulating feeding, memory, and anxiety-like behavioral responses to ghrelin. Biochem Biophys Res Commun 2004, 313:635-641.
12. Cruz A.P.M., Frei F., Graeff F.G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol Biochem Behav 1994, 49:171-176.
13. Cryan J.F., Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 2005, 4:775-790.
14. de Graaf R., Bijl R.V., Smith F., Vollebergh W.A.M., Spijker J. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Am J Psychiatry 2002, 159:620-629.
15. de la Mora M.P., Cardenas-Cachon L., Vazquez-Garcia M., Crespo-Ramirez M., Jacobsen K., Hoistad M., Agnati L., Fuxe K. Anxiolytic effects of intra-amygdaloid injection of the D1 antagonist SCH23390 in the rat. Neurosci Lett 2005, 377:101-105.
16. Diano S., Farr S.A., Benoit S.C., McNay E.C., da Silva I., Horvath B., Gaskin F.S., Nonaka N., Jaeger L.B., Banks W.A., Morley J.E., Pinto S., Sherwin R.S., Xu L., Yamada K.A., Sleeman M.W., Tschop M.H., Horvath T.L. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 2006, 9:381-388.
17. Drevets W.C., Bogers W., Raichle M.E. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol 2002, 12:527-544.
18. Emul H.M., Serteser M., Kurt E., Ozbulut O., Guler O., Gecici O. Ghrelin and leptin levels in patients with obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1270-1274.
19. Escorihuela R.M., Fernandez-Teruel A., Gil L., Aguilar R., Tobena A., Driscoll P. Inbred roman high- and low-avoidance rats: differences in anxiety, novelty-seeking, and shuttlebox behaviors. Physiol Behav 1999, 67:19-26.
20. File S.E., Seth P. A review of 25 years of the social interaction test. Eur J Pharmacol 2003, 463:35-53.
21. Frank E., Salchner P., Aldag J.M., Salome N., Singewald N., Landgraf R., Wigger A. Genetic predisposition to anxiety-related behavior determines coping style, neuroendocrine responses, and neuronal activation during social defeat. Behav Neurosci 2006, 120:60-71.
22. Guan X.M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Sirinathsinghji D.J.S., Smith R.G., VanderPloeg L.H.T., Howard A.D. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Mol Brain Res 1997, 48:23-29.
23. Hajos M., Sharp T. Burst-firing activity of presumed 5-HT neurones of the rat dorsal raphe nucleus: electrophysiological analysis by antidromic stimulation. Brain Res 1996, 740:162-168.
24. Henderson N.D., Turri M.G., DeFries J.C., Flint J. QTL analysis of multiple behavioral measures of anxiety in mice. Behav Genet 2004, 34:267-293.
25. Hinojosa F.R., Spricigo L., Izidio G.S., Bruske G.R., Lopes D.M., Ramos A. Evaluation of two genetic animal models in behavioral tests of anxiety and depression. Behav Brain Res 2006, 168:127-136.
26. Jerlhag E., Egecioglu E., Dickson S.L., Andersson M., Svensson L., Engel J.A. Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict Biol 2006, 11:45-54.
27. Jerlhag E., Egecioglu E., Dickson S.L., Douhan A., Svensson L., Engel J.A. Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol 2007, 12:6-16.
28. Jerlhag E., Egecioglu E., Landgren S., Salome N., Heilig M., Moechard D., Datta R., Perissoud D., Dickson S.L., Engel J.A. Requirement of central ghrelin signaling for alcohol reward. Proc Natl Acad Sci U S A 2009, 106:11318-11323.
29. Jiang H., Betancourt L., Smith R.G. Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers. Mol Endocrinol 2006, 20:1772-1785.
30. Kanehisa M., Akiyoshi J., Kitaichi T., Matsushita H., Tanaka E., Kodama K., Hanada H., Isogawa K. Administration of antisense DNA for ghrelin causes an antidepressant and anxiolytic response in rats. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:1403-1407.
31. Kessler R.C., DuPont R.L., Berglund P., Wittchen H.U. Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am J Psychiatry 1999, 156:1915-1923.
32. Klimek V., Schenck J.E., Han H., Stockmeier C.A., Ordway G.A. Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study. Biol Psychiatry 2002, 52:740-748.
33. Kluge M., Schussler P., Schmid D., Uhr M., Kleyer S., Yassouridis A., Steiger A. Ghrelin plasma levels are not altered in major depression. Neuropsychobiology 2009, 59:199-204.
34. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
35. Kola B., Farkas I., Christ-Crain M., Wittmann G., Lolli F., Amin F., Harvey-White J., Liposits Z., Kunos G., Grossman A.B., Fekete C., Korbonits M. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS One 2008, 3:e1797.
36. Korbonits M., Goldstone A.P., Gueorguiev M., Grossman A.B. Ghrelin-a hormone with multiple functions. Front Neuroendocrinol 2004, 25:27-68.
37. Kurt E., Guler O., Serteser M., Cansel N., Ozbulut O., Altinbas K., Alatas G., Savas H., Gecici O. The effects of electroconvulsive therapy on ghrelin, leptin and cholesterol levels in patients with mood disorders. Neurosci Lett 2007, 426:49-53.
38. Liebsch G., Landgraf R., Gerstberger R., Probst J.C., Wotjak C.T., Engelmann M., Holsboer F., Montkowski A. Chronic infusion of a Crh(1) receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul Pept 1995, 59:229-239.
39. Liu J., Garza J.C., Bronner J., Kim C.S., Zhang W., Lu X.Y. Acute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetine. Psychopharmacology 2010, 207:535-545.
40. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
41. Lu X.Y. The leptin hypothesis of depression: a potential link between mood disorders and obesity?. Curr Opin Pharmacol 2007, 7:648-652.
42. Lu X.Y., Kim C.S., Frazer A., Zhang W. Leptin: a potential novel antidepressant. Proc Natl Acad Sci U S A 2006, 103:1593-1598.
43. Lutter M., Sakata I., Osborne-Lawrence S., Rovinsky S.A., Anderson J.G., Jung S., Birnbaum S., Yanagisawa M., Elmquist J.K., Nestler E.J., Zigman J.M. The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci 2008, 11:752-753.
44. Malik S., McGlone F., Bedrossian D., Dagher A. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab 2008, 7:400-409.
45. Martin-Ruiz R., Ugedo L. Electrophysiological evidence for postsynaptic 5-HT(1A) receptor control of dorsal raphe 5-HT neurones. Neuropharmacology 2001, 41:72-78.
46. Moody T.W., Merali Z., Crawley J.N. The effects of anxiolytics and other agents on rat grooming behavior. Ann N Y Acad Sci 1988, 525:281-290.
47. Nakashima K., Akiyoshi J., Hatano K., Hanada H., Tanaka Y., Tsuru J., Matsushita H., Kodama K., Isogawa K. Ghrelin gene polymorphism is associated with depression, but not panic disorder. Psychiatr Genet 2008, 18:257.
48. Nithianantharajah J., Murphy M. Auditory specific fear conditioning results in increased levels of synaptophysin in the basolateral amygdala. Neurobiol Learn Mem 2008, 90:36-43.
49. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant reatments. Nature 1977, 226:730-732.
50. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003, 463:3-33.
51. Ramos A., Mormede P. Stress and emotionality: a multidimensional and genetic approach. Neurosci Biobehav Rev 1998, 22:33-57.
52. Rotzinger S., Lovejoy D.A., Tan L.A. Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides 2010, 31:736-756.
53. Sajdyk T.J., Shekhar A. Excitatory amino acid receptor antagonists block the cardiovascular and anxiety responses elicited by gamma-aminobutyric acid, receptor blockade in the basolateral amygdala of rats. J Pharmacol Exp Ther 1997, 283:969-977.
54. Salome N., Hansson C., Taube M., Gustafsson-Ericson L., Egecioglu E., Karlsson-Lindahl L., Fehrentz J.A., Martinez J., Perrissoud D., Dickson S.L. On the central mechanism underlying ghrelin's chronic pro-obesity effects in rats: new insights from studies exploiting a potent ghrelin receptor antagonist. J Neuroendocrinol 2009, 21:777-785.
55. Schellekens H., Dinan T.G., Cryan J.F. Lean mean fat reducing "ghrelin" machine: hypothalamic ghrelin and ghrelin receptors as therapeutic targets in obesity. Neuropharmacology 2010, 58:2-16.
56. Schmid D.A., Wichniak A., Uhr M., Ising M., Brunner H., Held K., Weikel J.C., Sonntag A., Steiger A. Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine. Neuropsychopharmacology 2006, 31:832-844.
57. Schussler P., Uhr M., Ising M., Weikel J.C., Schmid D.A., Held K., Mathias S., Steiger A. Nocturnal ghrelin, ACTH, GH and cortisol secretion after sleep deprivation in humans. Psychoneuroendocrinology 2006, 31:915-923.
58. Steimer T., Driscoll P. Divergent stress responses and coping styles in psychogenetically selected roman high-(RHA) and low-(RLA) avoidance rats: behavioural, neuroendocrine and developmental aspects. Stress 2003, 6:87-100.
59. Steimer T., la Fleur S., Schulz P.E. Neuroendocrine correlates of emotional reactivity and coping in male rats from the Roman high (RHA/Verh)- and low (RLA/Verh)-avoidance lines. Behav Genet 1997, 27:503-512.
60. Stein M.B., Goldin P.R., Sareen J., Zorrilla L.T.E., Brown G.G. Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry 2002, 59:1027-1034.
61. Stevanovic D., Milosevic V., Starcevic V.P., Severs W.B. The effect of centrally administered ghrelin on pituitary ACTH cells and circulating ACTH and corticosterone in rats. Life Sci 2007, 80:867-872.
62. Temel Y., Boothman L.J., Blokland A., Magill P.J., Steinbusch H.W.M., Visser-Vandewalle V., Sharp T. Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus. Proc Natl Acad Sci U S A 2007, 104:17087-17092.
63. Theander-Carrillo C., Wiedmer P., Cettour-Rose P., Szanto I., Tschopp M.H., Jeanrenaud F.R. Central ghrelin infusion regulates adipocyte glucose and lipid metabolism in rats. Int J Obes 2006, 30:S69.
64. Toth K., Laszlo K., Lenard L. Role of intraamygdaloid acylated-ghrelin in spatial learning. Brain Res Bull 2010, 81:33-37.
65. Toth K., Laszlo K., Lukacs E., Lenard L. Intraamygdaloid microinjection of acylated-ghrelin influences passive avoidance learning. Behav Brain Res 2009, 202:308-311.
66. Treuer T. The potential role of ghrelin in the mechanism of sleep deprivation therapy for depression. Sleep Med Rev 2007, 11:523-524. author reply 524-525.
67. Tschöp M., Smiley D.L., Heiman M.L. Ghrelin induces adiposity in rodents. Nature 2000, 407:908-913.
68. Tucci S.A., Rogers E.K., Korbonits M., Kirkham T.C. The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin. Br J Pharmacol 2004, 143:520-523.
69. Vandermaelen C.P., Aghajanian G.K. Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat-brain slices. Brain Res 1983, 289:109-119.
70. Wellman P.J., Hollas C.N., Elliott A.E. Systemic ghrelin sensitizes cocaine-induced hyperlocomotion in rats. Regul Pept 2008, 146:33-37.
71. Westfall P.H., Young S.S. Resampling-based multiple testing 1993, Wiley, New York.
72. Zigman J.M., Jones J.E., Lee C.E., Saper C.B., Elmquist J.K. Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 2006, 494:528-548.